A Study of CCX140-B in Subjects With FSGS

Clinical trial NCT03536754 · COMPLETED

Trial details

NCT number: NCT03536754
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

FSGS Focal Segmental Glomerulosclerosis Glomerulosclerosis

Start date: 2018-05-17
Primary completion: 2020-02-19
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.